Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtre
Ajouter des filtres








Gamme d'année
1.
SPJ-Saudi Pharmaceutical Journal. 1997; 5 (2-3): 110-113
Dans Anglais | IMEMR | ID: emr-47058

Résumé

The anti-inflammatory activity of the volatile oil [v.o.] of Nigella sativa L. seeds and its active principle thymoquinone has been examined using carrageenan-induced oedema in rat hind paws and cotton seed pellet granuloma in rats. Both the v.o. and thymoquinone were found to produce a significant dose-dependent anti-inflammatory effect as evidenced by the significant inhibition of oedema formation and reduction of the granuloma weight. The v.o. [0.66 ml and 1.55 ml/Kg, Lp.] inhibited rat hind paw oedema formation by 64.12% and 96.26%, while thymoquinone [0.5, 1.0, 5 mg/Kg, Lp.] caused a reduction of38.85%, 56.63% and 104.88%, respectively. Indomethacin [3 and 9 mg/Kg, Lp.] inhibited the oedema by 46.90% and 67.83%, respectively. In addition, the v.o. [0.33 ml and 0.66 ml/Kg, Lp.] inhibited granuloma formation by 17.64% and 46.86%, while thymoquinone [3 and 5 mg/Kg, i.p.] reduced granuloma weight by 13.04% and 48.09%. These effects were nearly comparable to indomethacin [3 mg/Kg, i.p.] which reduced granuloma weight by 34.37%. It was suggested that the anti-inflammatory activity of the v.o. of Nigella sativa seeds may be due to inhibiting the generation of eicosanoids and lipid peroxidation


Sujets)
Animaux de laboratoire , Graines , Plantes médicinales , Anti-inflammatoires/pharmacologie , Rats , Oedème , Gossypium , Granulome/traitement médicamenteux , Inflammation/traitement médicamenteux , Carragénane , Indométacine/pharmacologie
SÉLECTION CITATIONS
Détails de la recherche